For Risk-Tolerant Investors, Cancer Genetics, Inc. (NASDAQ:CGIX) Is Worth A Shot

Retrieved on: 2021-01-29 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

For Risk-Tolerant Investors, Cancer Genetics, Inc. (NASDAQ:CGIX) Is Worth A Shot. View article details on hiswai:

Excerpt

In total, 16 institutions holds shares in the company, led by Renaissance Technologies, LLC. As of Sep 29, 2020, the company held over 193.4 ...

Article found on: marketingsentinel.com